Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joshua Ting
Institutions:
Institute of Cancer Research,
Royal Marsden Hospital
Observed institutions:
Institute of Cancer Research,
Royal Marsden Hospital
ORCID:
0000-0001-7204-5767
Observed ORCID:
0000-0001-7204-5767
OpenAlex ID:
A5128566096
Abstract 6457: Phase I study of STA551 (STA) a tumor-selective CD137 agonist, as monotherapy and in combination with atezolizumab (atezo) using CD8 PET imaging to assess pharmacodynamic effects
2026
·
Udai Banerji
, Diogo Silva
, et al.
·
Cancer Research
·
1
Drug Development in Non-Oncogene-Addicted Non-Small Cell Lung Cancer
2026
·
Pedro Cruz
, Cristina Boixareu
, et al.
·
Cancers
·
1
PDF
Correction: Cruz et al. Drug Development in Non-Oncogene-Addicted Non-Small Cell Lung Cancer. Cancers 2026, 18, 880
2026
·
Pedro Cruz
, Cristina Boixareu
, et al.
·
Cancers
PDF
Show more works
View as search
Works count:
3
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type